Teradyne to Announce Fourth Quarter and Full Year 2021 Resul...| MENAFN.COM

Friday, 21 January 2022 12:17 GMT

Teradyne to Announce Fourth Quarter and Full Year 2021 Results


(MENAFN- GlobeNewsWire - Nasdaq)

NORTH READING, Mass., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Teradyne, Inc. (NASDAQ: TER) will release financial results for the fourth quarter and full year 2021 on Wednesday, January 26, 2022 at 5:00 p.m. Eastern Time (ET) or later.

A conference call to discuss the fourth quarter and full year results, along with management's business outlook, will follow at 8:30 a.m. ET, Thursday, January 27, 2022.

Interested investors should access the webcast at investors.teradyne.com/events-presentations at least five minutes before the call begins. Presentation materials will be available starting at 8:30 a.m. ET.

A replay will be available on the Teradyne website at – investors.teradyne.com .

About Teradyne
Teradyne (NASDAQ:TER) brings high-quality innovations such as smart devices, life-saving medical equipment and data storage systems to market, faster. Its advanced test solutions for semiconductors, electronic systems, wireless devices and more ensure that products perform as they were designed. Its Industrial Automation offerings include collaborative and mobile robots that help manufacturers of all sizes improve productivity and lower costs. In 2020, Teradyne had revenue of $3.1 billion and today employs over 5,800 people worldwide. For more information, visit teradyne.com . Teradyne® is a registered trademark of Teradyne, Inc. in the U.S. and other countries.

For more information, contact:
Andrew Blanchard
Investor Relations
Tel 978.370.2425

 




MENAFN14012022004107003653ID1103540574


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.